Category Archives: Immune Therapy

Cryo Immuno Therapy Part 3

Posted on July 6, 2015 by "Coach" Israel Barken M.D.

Part 3 of the lecture about Cryo Immune Therapy given by Dr. Israel  Barken from the Prostate Research and Education Foundation.  Dr. Barken describes Cryo immunotherapy. The reasons why there are no consistent immune response after cryoablation are discussed.  Suggestions for … Continue reading →

Posted in Cryo Immunotherapy, Cryoablation, Immune Therapy, Metastatic Prostate Cancer Disease, Prostate Cancer, Treatments for Prostate Cancer | Leave a comment

Cryo Immunotherapy Part 1

Posted on June 19, 2015 by "Coach" Israel Barken M.D.

Dr. Barken presents the history of cryoablation and the new developments in the field of immunology which will create enhancement of the Immune effect on metastatic disease in response to cryoablation of local tumor.

Posted in Cryo Immunotherapy, Cryoablation, Immune Therapy, Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer, Vaccine | Leave a comment

Cryoablation Immuno Therapy

Posted on June 9, 2015 by "Coach" Israel Barken M.D.

Clinical Study Phase I Cryoimmunotherapy against Metastatic prostate Cancer Disease. Dr. Israel Barken, the Medical Director of the Prostate Cancer Research and Education, presents a clinical study phase I, featuring cryosurgery plus immuno-Modulator – Cyclophosphamide and Anti CTLA 4 Antibodies- … Continue reading →

Posted in Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Prostate Cancer, Treatments for Prostate Cancer, Vaccine | Leave a comment

Combining active immunotherapy and immune checkpoint inhibitors in prostate cancer

Posted on May 3, 2015 by "Coach" Israel Barken M.D.

Phase I study approach of priming the immune system with Prostvac vaccination, intensified immunotherapy with Ipilimumab to further enhance the immune response.  This was presented by Hapreet Singh M.D. from the National Cancer Institute. Genentech video explaining the “Security Checkpoint System” … Continue reading →

Posted in Ask Dr. Barken, Immune Therapy, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer, Vaccine | Leave a comment

Prostvac Vaccination for Localized Prostate Cancer Disease

Posted on March 6, 2015 by "Coach" Israel Barken M.D.

Prostvac in Preventing Disease Progression in Patients with Localized Cancer Undergoing Active Surveillance. What is unique about  this vaccine study , is the fact that it is given to patients with localized disease.  Practically, the patient gets a series of vaccination … Continue reading →

Posted in Active Surveillance, Clinical Trials, Immune Therapy, Treatments for Prostate Cancer, Vaccine | Tagged , | Leave a comment

Phase III Prostvac Clinical Study

Posted on December 18, 2014 by "Coach" Israel Barken M.D.

Immune Therapy is an important tool for advanced prostate cancer disease, especially in older patients for whom chemotherapy is excluded because of other serious medical problems. Dr. Barken presents the Prostvac Clinical Study Phase III with a video clip featuring … Continue reading →

Posted in Active Surveillance, Ask Dr. Barken, Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Metastatic Disease, Prostate Cancer, PSA | Leave a comment

New Prostate Cancer Immunotherapy- Prostvac

Posted on November 28, 2014 by "Coach" Israel Barken M.D.

Dr. Barken introduces the New Prostate Cancer Immune Therapy for earlier stages of Prostate Cancer.  Please watch the video below and see what  he learned at the National Cancer Institute recent conference mentioned above. Dr. James Gulley explains the Prostvac … Continue reading →

Posted in Clinical Trials, Immune Therapy, Prostate Cancer, PSA, Treatments for Prostate Cancer | Tagged | Leave a comment

Enzalutamide and Prostvac for patients with PSA only disease after primary treatment

Posted on October 22, 2014 by "Coach" Israel Barken M.D.

This very significant development could become the standard treatment for prostate cancer in the future.   Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer. NIH Study- Recruiting- ClinicalTrials.gov  Identifier: NCT01875250

Posted in Immune Therapy, Prostate Cancer, PSA, Radiation Therapy, Radical Prostatectomy | Leave a comment

Sexual Funcation, Immune System, Choline 11 PET scan, Multi Parametric MRI and Decision Making Model for Prostate Cancer Disease

Posted on September 15, 2013 by "Coach" Israel Barken M.D.

Click here to view your video

Posted in Choline 11 PET Scan, Decision Making, Diagnosis, Imaging, Immune Therapy, MRI, PET scans, Sexual Dysfunction, Treatments for Prostate Cancer | Leave a comment

Dr. Mark Scholz discusses PCRI Conference

Posted on July 15, 2013 by "Coach" Israel Barken M.D.

Dr. Israel Barken from the Prostate Cancer Research and Education Foundation, interviews Dr. Mark Scholz from Prostate Oncology Specialists in Marina Del Rey , California

Posted in Immune Therapy, Treatments for Prostate Cancer | Tagged , | Leave a comment